Donor drop and expansion jitters give CSL a bloody nose

CSL is looking to appeal the US-Mexican border decision arguing that it threatens the health of patients with life-threatening conditions that require plasma-based treatments. But the biotech is wading into the muddy geopolitical waters of sovereign borders and the US-Mexican border has long…